4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000004
Chief Medical Officer sold 7,000 shares at an average $31.81 ($222,704)
- Chief Medical Officer acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/form4.xml…